News | Radiation Therapy | September 07, 2016

ASTRO Announces Featured Clinical Trials and Research for 2016 Annual Meeting

Press program will highlight innovations in cancer care from 15 leading studies in five news briefings held live on-site and via webcast

ASTRO 2016 annual meeting, clinical trials and research, press program, radiation therapy

September 7, 2016 — The American Society for Radiation Oncology (ASTRO) announced the press program for its 58th Annual Meeting, Sept. 25-28 in Boston. The program includes multiple reports from phase III clinical trials, researchers from leading institutions in the United States and abroad, and examinations of a range of cancer types and patient populations. Researchers will share their findings in a series of briefings held on-site at the Boston Convention & Exhibition Center and webcast to registered press.

The news briefing schedule is as follows:

Meeting Overview & Report on ASTRO Initiatives

  • Sunday, Sept. 25, 2:45 - 3:15 p.m. ET
  • Features David C. Beyer, M.D., FASTRO, current president and incoming chair of ASTRO

Refining Treatment Decisions

  • Monday, Sept. 26, 8:00 - 9:00 a.m. ET
  • Features studies evaluating conventional versus accelerated treatment approaches for brain metastases, lung cancer and prostate cancer

Expanding Access to Care

  • Monday, Sept. 26, 10:30 - 11:30 a.m. ET
  • Features studies on expanding care to overlooked or growing patient populations, including elderly patients, African Americans, developing countries and veterans

Advances in Prostate Cancer Care

  • Tuesday, Sept. 27, 8:00 - 9:00 a.m. ET
  • Features large trials and multi-institution studies examining treatment advances in brachytherapy, teletherapy and biomarker subtyping for prostate cancer

Innovations in RT Delivery

  • Tuesday, Sept. 27, 1:30 p.m. - 2:30 p.m. ET
  • Features reports of how new approaches to radiation therapy delivery impact disease control and quality of life for gynecologic, breast and pediatric brain cancers

 

The 2016 ASTRO Annual Meeting is expected to attract more than 11,000 attendees from across the globe, including oncologists from all disciplines and members of the entire radiation oncology team. The meeting will feature abstracts, scientific and educational presentations on radiation oncology clinical trials and research, and keynote addresses from former U.S. Secretary of Health and Human Services Kathleen Sebelius, the current chair and CEO of the Massachusetts General Physicians Organization and a top safety executive from Delta Air Lines.

Led by Beyer, the 2016 meeting is organized around the theme, “Enhancing Value, Improving Outcomes,” echoing growing calls from policy makers, physicians and patients for value-based health care. Concurrent with the scientific and educational program, more than 200 exhibitors will demonstrate the latest cutting-edge technology and medical device innovations for radiation oncology.

For more information: www.astro.org

Related Content

Life Image and Mendel.ai Bringing Artificial Intelligence to Clinical Trial Development
News | Artificial Intelligence | November 15, 2018
Life Image and Mendel.ai announced a new strategic partnership that will facilitate the adoption and enhancement of...
Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...